Cite
HARVARD Citation
Weycker, D. et al. (2019). Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis: a retrospective evaluation using Medicare claims. Current medical research and opinion. pp. 725-730. [Online].